Filing Details
- Accession Number:
- 0001493152-24-047695
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-25 20:30:12
- Reporting Period:
- 2024-11-25
- Accepted Time:
- 2024-11-25 20:30:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1962011 | Kairos Pharma Ltd. | KAPA | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1870016 | Ramachandran Murali | C/O Kairos Pharma, Ltd. 2355 Westwood Blvd, #139 Los Angeles CA 90064 | Vp Of Research And Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-11-25 | 200 | $1.59 | 133,057 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
